<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00255671</url>
  </required_header>
  <id_info>
    <org_study_id>CASE4Z05</org_study_id>
    <secondary_id>P30CA043703</secondary_id>
    <secondary_id>CASE4Z05</secondary_id>
    <secondary_id>CCF-8078</secondary_id>
    <nct_id>NCT00255671</nct_id>
  </id_info>
  <brief_title>Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders</brief_title>
  <official_title>Prospective Study on the Short-Term Adverse Effects From Gamma Knife Radiosurgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Case Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Case Comprehensive Cancer Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Learning about the side effects of stereotactic radiosurgery in patients with
      brain tumors or other brain disorders may help doctors plan treatment and help patients live
      more comfortably.

      PURPOSE: This clinical trial is studying the acute side effects in patients who are
      undergoing stereotactic radiosurgery for brain tumors or other brain disorders.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

        -  Determine the incidence and types of acute complications in patients undergoing
           stereotactic radiosurgery for brain tumors or other brain disorders.

        -  Determine the time frame for development and resolution of these complications in these
           patients.

        -  Determine the severity of these complications in these patients.

      OUTLINE: Patients undergo stereotactic radiosurgery. Patients also complete questionnaires
      about the side effects they experience from radiosurgery. The questionnaires are completed at
      baseline and at 1 week, 1 month, and 2 months after radiosurgery.

      PROJECTED ACCRUAL: A total of 94 patients will be accrued for this study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2005</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Short-term adverse effects as assessed by a questionnaire</measure>
    <time_frame>at 1 week, 1 month, and 2 months</time_frame>
    <description>Patients undergo stereotactic radiosurgery. Patients also complete questionnaires about the side effects they experience from radiosurgery. The questionnaires are completed at baseline and at 1 week, 1 month, and 2 months after radiosurgery.</description>
  </primary_outcome>
  <enrollment type="Actual">76</enrollment>
  <condition>Brain and Central Nervous System Tumors</condition>
  <condition>Metastatic Cancer</condition>
  <condition>Radiation Toxicity</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>Patients complete questionnaires about the side effects they experience from radiosurgery. The questionnaires are completed at baseline and at 1 week, 1 month, and 2 months after radiosurgery.</description>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Determine the incidence and types of acute complications in patients undergoing stereotactic
      radiosurgery for brain tumors or other brain disorders.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Diagnosis of brain tumor or other brain disorder, including, but not limited to, 1 of
             the following:

               -  Primary brain tumors

               -  Brain metastases

               -  Acoustic neuromas

               -  Pituitary adenomas

               -  Parkinson's disease

               -  Cluster headaches

               -  Glomus jugulare

               -  Epilepsy

               -  Obsessive compulsive disorder

               -  Arteriovenous malformations

               -  Trigeminal neuralgia

          -  Eligible for and scheduled to undergo stereotactic radiosurgery

        PATIENT CHARACTERISTICS:

        Performance status

          -  Not specified

        Life expectancy

          -  Not specified

        Hematopoietic

          -  Not specified

        Hepatic

          -  Not specified

        Renal

          -  Not specified

        Other

          -  No physical or mental limitation that would preclude study compliance

        PRIOR CONCURRENT THERAPY:

        Endocrine therapy

          -  Concurrent steroids allowed

        Radiotherapy

          -  No prior stereotactic radiosurgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Suh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic Taussig Cancer Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2005</study_first_submitted>
  <study_first_submitted_qc>November 18, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2005</study_first_posted>
  <last_update_submitted>October 1, 2015</last_update_submitted>
  <last_update_submitted_qc>October 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>radiation toxicity</keyword>
  <keyword>tumors metastatic to brain</keyword>
  <keyword>adult anaplastic astrocytoma</keyword>
  <keyword>adult anaplastic ependymoma</keyword>
  <keyword>adult anaplastic meningioma</keyword>
  <keyword>adult anaplastic oligodendroglioma</keyword>
  <keyword>adult brain stem glioma</keyword>
  <keyword>adult central nervous system germ cell tumor</keyword>
  <keyword>adult choroid plexus tumor</keyword>
  <keyword>adult craniopharyngioma</keyword>
  <keyword>adult diffuse astrocytoma</keyword>
  <keyword>adult ependymoblastoma</keyword>
  <keyword>adult ependymoma</keyword>
  <keyword>adult giant cell glioblastoma</keyword>
  <keyword>adult gliosarcoma</keyword>
  <keyword>adult medulloblastoma</keyword>
  <keyword>adult melanocytic lesion</keyword>
  <keyword>adult meningeal hemangiopericytoma</keyword>
  <keyword>adult meningioma</keyword>
  <keyword>adult myxopapillary ependymoma</keyword>
  <keyword>adult oligodendroglioma</keyword>
  <keyword>adult papillary meningioma</keyword>
  <keyword>adult pineoblastoma</keyword>
  <keyword>adult pineocytoma</keyword>
  <keyword>adult subependymoma</keyword>
  <keyword>adult supratentorial primitive neuroectodermal tumor (PNET)</keyword>
  <keyword>adult grade I meningioma</keyword>
  <keyword>adult grade II meningioma</keyword>
  <keyword>adult grade III meningioma</keyword>
  <keyword>adult mixed glioma</keyword>
  <keyword>recurrent adult brain tumor</keyword>
  <keyword>adult pilocytic astrocytoma</keyword>
  <keyword>adult glioblastoma</keyword>
  <keyword>ACTH-producing pituitary tumor</keyword>
  <keyword>growth hormone-producing pituitary tumor</keyword>
  <keyword>nonfunctioning pituitary tumor</keyword>
  <keyword>prolactin-producing pituitary tumor</keyword>
  <keyword>recurrent pituitary tumor</keyword>
  <keyword>TSH producing pituitary tumor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Nervous System Neoplasms</mesh_term>
    <mesh_term>Central Nervous System Neoplasms</mesh_term>
    <mesh_term>Radiation Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

